Jain Global’s Akero Therapeutics AKRO Stock Holding History

Jain Global’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-325,132	Closed	-$15.4M	–	1199
2025 Q3	$15.4M	Sell	325,132 -20,240	-6%	-$980K	0.07%	169
2025 Q2	$18.4M	Buy	345,372 +222,475	+181%	+$10.1M	0.14%	137
2025 Q1	$4.97M	Buy	+122,897	New	+$5.21M	0.06%	226

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jain Global's AKRO Position: Q4 2025 in Review

Jain Global sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 325,132 shares — an estimated $15.4M sold.

Jain Global first reported a position in AKRO in Q1 2025 and held it in 3 quarters. The position peaked at $18.4M in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Jain Global reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Jain Global sold 325,132 Akero Therapeutics shares in Q4 2025, an estimated $15.4M.
Jain Global first reported a position in Akero Therapeutics in Q1 2025 and held it in 3 quarters.
Jain Global's Akero Therapeutics position peaked at $18.4M in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Jain Global's 13F filing for Q4 2025, filed 17 Feb 2026.